DK554084A - 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol - Google Patents

26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol Download PDF

Info

Publication number
DK554084A
DK554084A DK554084A DK554084A DK554084A DK 554084 A DK554084 A DK 554084A DK 554084 A DK554084 A DK 554084A DK 554084 A DK554084 A DK 554084A DK 554084 A DK554084 A DK 554084A
Authority
DK
Denmark
Prior art keywords
dihydroxycholesterol
1alpha
hexafluoro
vitamin
derivatives
Prior art date
Application number
DK554084A
Other languages
English (en)
Other versions
DK165695B (da
DK554084D0 (da
DK165695C (da
Inventor
Hector F Deluca
Yoko Tanaka
Nobuo Ikekawa
Yoshiro Kobayashi
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK554084D0 publication Critical patent/DK554084D0/da
Publication of DK554084A publication Critical patent/DK554084A/da
Publication of DK165695B publication Critical patent/DK165695B/da
Application granted granted Critical
Publication of DK165695C publication Critical patent/DK165695C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK554084A 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol DK165695C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US28679081 1981-07-27
US06/286,790 US4358406A (en) 1981-07-27 1981-07-27 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US8200909 1982-07-06
PCT/US1982/000909 WO1983000335A1 (en) 1981-07-27 1982-07-06 26,26,26,27,27,27-HEXAFLUORO-1'alpha',25-DIHYDROXYCHOLECALCIFEROL AND PROCESS FOR PREPARING SAME
DK137083 1983-03-25
DK137083A DK162282C (da) 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden

Publications (4)

Publication Number Publication Date
DK554084D0 DK554084D0 (da) 1984-11-22
DK554084A true DK554084A (da) 1984-11-22
DK165695B DK165695B (da) 1993-01-04
DK165695C DK165695C (da) 1993-06-07

Family

ID=23100174

Family Applications (2)

Application Number Title Priority Date Filing Date
DK137083A DK162282C (da) 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden
DK554084A DK165695C (da) 1981-07-27 1984-11-22 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK137083A DK162282C (da) 1981-07-27 1983-03-25 Analogifremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholecalciferoler samt 26,26,26-27,27,27-hexafluor-1alfa,3beta,25-trihydroxycholest-5,7-dien til anvendelse som udgangsmateriale ved fremgangsmaaden

Country Status (14)

Country Link
US (1) US4358406A (da)
JP (1) JPS58501176A (da)
AU (2) AU552210B2 (da)
BE (1) BE893943A (da)
CH (2) CH655307A5 (da)
DE (2) DE3250034C2 (da)
DK (2) DK162282C (da)
FR (1) FR2510566B1 (da)
GB (2) GB2102806B (da)
IE (2) IE54370B1 (da)
IL (5) IL76091A (da)
IT (1) IT1157309B (da)
NL (1) NL8220265A (da)
WO (1) WO1983000335A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634692A (en) * 1981-08-28 1987-01-06 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
US4448726A (en) * 1983-05-11 1984-05-15 Wisconsin Alumni Research Foundation Ring A- and triene-modified vitamin D compounds
US4613594A (en) * 1984-11-16 1986-09-23 Hoffmann-La Roche Inc. Fluorinated vitamin D3 compounds
ZA859138B (en) * 1984-12-19 1986-08-27 Hoffmann La Roche Cholecalciferol derivatives
EP0205025A1 (en) * 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorine derivatives of vitamin D3 and cell differentiation-inducing agents containing the same as an active ingredient
US4619920A (en) * 1985-09-16 1986-10-28 Wisconsin Alumni Research Foundation 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
CA1314872C (en) 1986-04-25 1993-03-23 Toshio Nishizawa Fluorine derivatives of vitamin d _and process for producing the same
JPH0764804B2 (ja) * 1986-04-25 1995-07-12 住友製薬株式会社 活性型ビタミンｄ３のフッ素誘導体
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
BR9205983A (pt) * 1991-05-06 1994-08-02 Procter & Gamble Suplementos de cálcio e vitamina d combinados
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
AU5156593A (en) * 1992-10-16 1994-05-09 Chugai Seiyaku Kabushiki Kaisha Vitamin d derivative and process for producing the same
US5571802A (en) * 1993-02-19 1996-11-05 Wisconsin Alumni Research Foundation Method of treating post menopausal osteoporosis with hexafluro-vitamin D
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
US6080879A (en) * 1998-05-19 2000-06-27 Tetrionics, Inc. Hexafluoro-vitamin synthesis and crystallization method, solvent and product
MX2010007266A (es) * 2007-12-28 2010-11-30 Wisconsin Alumni Res Found Análogos de vitamina d, (20s)-23, 23-difluoro-2-metilen-19-nor-bis homopregnacalciferol.
SG2014006324A (en) 2009-01-27 2014-03-28 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN102655869B (zh) 2009-08-14 2016-08-10 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
US20150158903A1 (en) * 2011-09-08 2015-06-11 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
HK1222819A1 (zh) 2013-05-29 2017-07-14 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发
ES2536256B2 (es) * 2013-11-20 2016-02-01 Universidade De Santiago De Compostela Análogos de vitamina d con interés farmacéutico
MX376833B (es) 2015-07-06 2025-03-07 Sage Therapeutics Inc Oxiesteroles y metodos de uso de los mismos.
CN114272249A (zh) 2016-04-01 2022-04-05 萨奇治疗股份有限公司 氧甾醇及其使用方法
EP3519422B1 (en) 2016-09-30 2022-08-31 Sage Therapeutics, Inc. C7 substituted oxysterols and these compounds for use as nmda modulators
ES2952106T3 (es) 2016-10-18 2023-10-27 Sage Therapeutics Inc Oxisteroles y procedimientos de utilización de los mismos
CN111960938B (zh) * 2020-08-20 2022-06-17 甘肃皓天医药科技有限责任公司 用于制备氟骨化醇的中间体的制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45897A (en) * 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
US4199518A (en) * 1978-03-30 1980-04-22 Diamond Shamrock Corporation 1α,3β-Dihydroxy-steroid-5-enes from 1α,2α-epoxy-steroid-4,6-dien-3-ones
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4226788A (en) * 1979-03-28 1980-10-07 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol

Also Published As

Publication number Publication date
DK137083D0 (da) 1983-03-25
AU6056086A (en) 1986-12-18
GB2118556B (en) 1985-02-27
IE891226L (en) 1983-01-27
DK137083A (da) 1983-03-25
AU586267B2 (en) 1989-07-06
DE3248900T1 (de) 1983-07-07
IT8222574A0 (it) 1982-07-26
IL76091A (en) 1987-12-31
NL8220265A (nl) 1983-06-01
DK165695B (da) 1993-01-04
IL76090A (en) 1987-12-31
IL66351A (en) 1987-12-31
JPH0348903B2 (da) 1991-07-25
IL76091A0 (en) 1985-12-31
DK554084D0 (da) 1984-11-22
IL66351A0 (en) 1982-11-30
GB2118556A (en) 1983-11-02
BE893943A (fr) 1982-11-16
FR2510566A1 (fr) 1983-02-04
GB8311517D0 (en) 1983-06-02
US4358406A (en) 1982-11-09
CH655307A5 (de) 1986-04-15
DK162282C (da) 1992-03-16
DK165695C (da) 1993-06-07
IE54370B1 (en) 1989-09-13
DK162282B (da) 1991-10-07
IE54369B1 (en) 1989-09-13
IE821797L (en) 1983-01-27
FR2510566B1 (fr) 1985-06-28
WO1983000335A1 (en) 1983-02-03
IL76090A0 (en) 1985-12-31
AU552210B2 (en) 1986-05-22
JPS58501176A (ja) 1983-07-21
IT1157309B (it) 1987-02-11
GB2102806A (en) 1983-02-09
GB2102806B (en) 1985-02-27
DE3250034C2 (da) 1991-02-28
CH656134A5 (de) 1986-06-13
DE3248900C2 (da) 1990-12-13
AU8760582A (en) 1983-03-17

Similar Documents

Publication Publication Date Title
DK554084A (da) 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
ES511955A0 (es) "procedimiento para la preparacion de derivados de cefem".
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
MX6983E (es) Procedimiento de preparacion de derivados 1,3-dihidro-6-metil-7-hidroxifuro-(3,4-c)-piridina
YU45719B (sh) Postopek za pripravo mešano substituiranih enantiomerno čistih 1,2-diacil-sn-gli cero-3-fosfoholinov in 1,2-di-acil-sn-glicero-3-fosfoetanolaminov
ES514795A0 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina.
DE3865544D1 (de) Vitamin d3-derivate.
ES510888A0 (es) "procedimiento para la produccion de derivados de 1-aril-2-azolileteno".
ES517862A0 (es) Derivados de alcanosulfonanilida.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
ES499299A0 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
IT8224053A0 (it) Procedimento per la preparazione di derivati di eburnamonina.
AR229519A1 (es) Procedimiento de preparacion de derivados de 2,3-dihidro-9-fenil-1h-pirazolo(1,2-a)-indazolio
ES508293A0 (es) "procedimiento para la preparacion de derivados de tiazolina".
ES513974A0 (es) Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol.
ES517288A0 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
NO157654C (no) Fremgangsmaate for fremstilling av 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-on-derivater.
IT1210473B (it) Procedimento per la preparazione di derivati ergolinici.
NO155666C (no) Fremgangsmaate for fremstilling av 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
ES516787A0 (es) "procedimiento para la fabricacion de derivados de 5-aminoisoxazol".
ES514844A0 (es) "procedimiento para la preparacion de derivados de 5(6)-fenil-sulfoniloxi-bencimidazol".
ES516225A0 (es) "procedimiento para la preparacion de derivados de bis-aminometil-antraquinona".
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.

Legal Events

Date Code Title Description
PBP Patent lapsed